Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance
King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today it has entered into a comprehensive drug substance development services agreement with a U.S. manufacturer. The company will provide analytical and process development and cGMP manufacture of Phio'
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-07-25 7:45 AM EDT | Phio Pharmaceuticals Corp.
Hemostemix Closes $2,969,600 Private Placement
Calgary, Alberta--(Newsfile Corp. - July 24, 2025) - Further to Hemostemix Inc's (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") June 26 and July 9th press releases, the Company is pleased to announce that it has completed its previously announced non-brokered private placement (the "Offering") for gross proceeds of $2,969,600 from the sale of 29,696,000 units of the Company (each, a "Unit") at a price of $0.10 per Unit. Each Unit was c
Biotechnology, Pharmaceuticals, Health
2025-07-24 10:24 AM EDT | Hemostemix Inc.
Telescope Innovations Selected to Join ALTA: the First US-Based Lithium Technology Accelerator
Vancouver, British Columbia--(Newsfile Corp. - July 24, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:4JU) ("Telescope Innovations", "Telescope", or the "Company") is a leader in intelligent automation platforms for accelerating chemical process development. The Company has been hand-picked to join the inaugural cohort of the Arkansas Lithium Technology Accelerator (ALTA), America's first lithium technology accelerator. WHAT IS ALTA? ALTA co
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-07-24 8:00 AM EDT | Telescope Innovations Corp.
Bachem Shows Strong Growth in the First Half of 2025
Bubendorf, Switzerland--(Newsfile Corp. - July 24, 2025) - Ad hoc announcement pursuant to Art. 53 LR Media Release Bachem shows stron
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2025-07-24 1:14 AM EDT | Bachem Holding AG